These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31014373)

  • 1. Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists.
    Müller M; Eastline J; Nagler M; Exadaktylos AK; Sauter TC
    Scand J Trauma Resusc Emerg Med; 2019 Apr; 27(1):48. PubMed ID: 31014373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
    Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
    Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists?
    Müller M; Chanias I; Nagler M; Exadaktylos AK; Sauter TC
    Scand J Trauma Resusc Emerg Med; 2021 Apr; 29(1):56. PubMed ID: 33823884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulants.
    Müller M; Traschitzger M; Nagler M; Arampatzis S; Exadaktylos AK; Sauter TC
    BMC Emerg Med; 2021 Sep; 21(1):105. PubMed ID: 34536992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
    Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
    Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study).
    Tazarourte K; Riou B; Tremey B; Samama CM; Vicaut E; Vigué B;
    Crit Care; 2014 Apr; 18(2):R81. PubMed ID: 24762166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants (DOAC) - Management of emergency situations.
    Lindhoff-Last E
    Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.
    Shin SS; Marsh EB; Ali H; Nyquist PA; Hanley DF; Ziai WC
    Neurocrit Care; 2020 Apr; 32(2):407-418. PubMed ID: 32034657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Patients with Acute Subdural Hemorrhage During Treatment with Direct Oral Anticoagulants.
    Beynon C; Brenner S; Younsi A; Rizos T; Neumann JO; Pfaff J; Unterberg AW
    Neurocrit Care; 2019 Apr; 30(2):322-333. PubMed ID: 30382531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
    Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
    Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of 4F-PCC to correct direct oral anticoagulant-induced coagulopathy: An observational analysis.
    Zheng Y; Tormey CA
    Transfus Med; 2020 Aug; 30(4):304-307. PubMed ID: 32342588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines.
    Milling TJ; Refaai MA; Sengupta N
    Dig Dis Sci; 2021 Nov; 66(11):3698-3714. PubMed ID: 33403486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases.
    Rivera-Caravaca JM; Harrison SL; Buckley BJR; Fazio-Eynullayeva E; Underhill P; Marín F; Lip GYH
    Cardiovasc Diabetol; 2021 Sep; 20(1):176. PubMed ID: 34481513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.
    Johansen M; Wikkelsø A; Lunde J; Wetterslev J; Afshari A
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010555. PubMed ID: 26151108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.